Redox-regulating sirtuins in aging, caloric restriction, and exercise. by Radak, Zsolt et al.
XML-IS
Our reference: FRB 11423 P-authorquery-vx
AUTHOR QUERY FORM
Journal: FRB
Please e-mail or fax your responses and any corrections to:
Article Number: 11423
E-mail: corrections.essd@elsevier.macipd.com
Fax: +44 1392 285878
Dear Author,
Please check your proof carefully and mark all corrections at the appropriate place in the proof (e.g., by using on-screen
annotation in the PDF file) or compile them in a separate list. Note: if you opt to annotate the file with software other than
Adobe Reader then please also highlight the appropriate place in the PDF file. To ensure fast publication of your paper please
return your corrections within 48 hours.
For correction or revision of any artwork, please consult http://www.elsevier.com/artworkinstructions.
Any queries or remarks that have arisen during the processing of your manuscript are listed below and highlighted by flags
in the proof. Click on the Q link to go to the location in the proof.
Location in
article
Query / Remark: click on the Q link to go
Please insert your reply or correction at the corresponding line in the proof
Q1 Please confirm that given names and surnames have been identified correctly and are presented in the
desired order.
Q2 GPX has been spelled out as glutathione peroxidase. OK?
Q3 Please provide initial for Sarga.
Q4 Please check the address for the corresponding author that has been added here, and correct if necessary.
Thank you for your assistance.
Please check this box if you have no
corrections to make to the PDF file ZQBX
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Graphical Abstract
Contents lists available at SciVerse ScienceDirect
journal homepage: www.elsevier.com/locate/freeradbiomed
Free Radical Biology and Medicine
Free Radical Biology and Medicine ] (]]]]) ]]]–]]]Redox-regulating sirtuins in aging, caloric restriction, and exercise
Zsolt Radak a,b, Erika Koltai a, Albert W. Taylor a, Mitsuru Higuchi a,b, Shuzo Kumagai c, Hideki Ohno d,
Sataro Goto a, Istvan Boldogh eQ1
a Research Institute of Sport Science, Semmelweis University, H-1085 Budapest, Hungary
b Graduate School of Sport Sciences, Waseda University, Saitama, Japan
c Institute of Health and Sports Science & Medicine and Graduate School of Human–Environment Studies, Kyushu
University, Kasuga, Fukuoka 816-8580, Japan
d Department of Molecular Predictive Medicine and Sport Science, School of Medicine, Kyorin University, Mitaka, Tokyo,
Japan
e University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA
Highlights
c Sirtuins deacetylate important transcription factors that adjust the redox balance. c Sirtuin-mediated protein stabilization was readily related to
housekeeping and redox regulation. c Sirtuins are able to alter the progress of aging. c Adaptation to caloric restriction and physical exercise
involves sirtuin-regulated pathways.
0891-5849/$ - see front matter & 2013 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.freeradbiomed.2013.01.004
Please cite this article as: Radak, Z; et al. Redox-regulating sirtuins in aging, caloric restriction, and exercise. Free Radic. Biol. Med.
(2013), http://dx.doi.org/10.1016/j.freeradbiomed.2013.01.004i
Free Radical Biology and Medicine ] (]]]]) ]]]–]]]
Review Article
Redox-regulating sirtuins in aging, caloric restriction, and exercise
Zsolt Radak a,b,n, Erika Koltai a, Albert W. Taylor a, Mitsuru Higuchi a,b, Shuzo Kumagai c, Hideki Ohno d,
Sataro Goto a, Istvan Boldogh eQ1
a Research Institute of Sport Science, Semmelweis University, H-1085 Budapest, Hungary
b Graduate School of Sport Sciences, Waseda University, Saitama, Japan
c Institute of Health and Sports Science & Medicine and Graduate School of Human–Environment Studies, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
d Department of Molecular Predictive Medicine and Sport Science, School of Medicine, Kyorin University, Mitaka, Tokyo, Japan
e University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA
a r t i c l e i n f o
Article history:
Received 24 July 2012
Received in revised form
3 January 2013
Accepted 5 January 2013
Keywords:
Aging
Sirtuins
Caloric restriction
Redox homeostasis
Antioxidants
DNA repair
Redox signaling
Exercise
Free radicals
a b s t r a c t
The consequence of decreased nicotinamide adenine dinucleotide (NADþ) levels as a result of oxidative
challenge is altered activity of sirtuins, which, in turn, brings about a wide range of modifications in
mammalian cellular metabolism. Sirtuins, especially SIRT1, deacetylate important transcription factors
such as p53, forkhead homeobox type O proteins, nuclear factor kB, or peroxisome proliferator-
activated receptor g coactivator 1a (which controls the transcription of pro- and antioxidant enzymes,
by which the cellular redox state is affected). The role of SIRT1 in DNA repair is enigmatic, because it
activates Ku70 to cope with double-strand breaks, but deacetylation of apurinic/apyrimidinic endonu-
clease 1 and probably of 8-oxoguanine-DNA glycosylase 1 decreases the activity of these DNA repair
enzymes. The protein-stabilizing effects of the NADþ-dependent lysine deacetylases are readily related
to housekeeping and redox regulation. The role of sirtuins in caloric restriction (CR)-related longevity in
yeast is currently under debate. However, in mammals, it seems certain that sirtuins are involved in
many cellular processes that mediate longevity and disease prevention via the effects of CR through the
vascular, neuronal, and muscular systems. Regular physical exercise-mediated health promotion also
involves sirtuin-regulated pathways including the antioxidant-, macromolecular damage repair-,
energy-, mitochondrial function-, and neuronal plasticity-associated pathways. This review critically
evaluates these findings and points out the age-associated role of sirtuins.
& 2013 Elsevier Inc. All rights reserved.
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Introduction
Sirtuins (silent information regulator 2 (Sir2)1 proteins)
belong to an ancient family of evolutionarily conserved NADþ-
dependent enzymes with deacetylase and/or mono-ADP-
ribosyltransferase activity and are implicated in diverse cellular
processes. The sirtuin family is ubiquitously distributed in mam-
mals, with seven homologs (SIRTs 1–7), and their expression/
activity shows organ and organelle specificity. Powerful protein
deacetylase activity of SIRT1, SIRT2, SIRT3, and SIRT5 has been
reported toward histones, whereas SIRT4, SIRT6, and SIRT7 have
no such detectable enzymatic activity on histone peptide sub-
strate [1,2]. SIRTs 3–5 are predominantly localized to the mito-
chondria. Mammalian sirtuins are closely involved in metabolism
[2–4], which is linked to the mitochondrial generation of reactive
oxygen species (ROS) [5,6]. SIRT1 is downstream in ROS signaling
because of a dependence on the availability of NAD, but it can be
important upstream in cellular regulators, including forkhead
homeobox type O factor 3 (FOXO3) [7], muscle-specific RING
finger protein 1 [8], and the v-Akt murine thymoma viral
oncogene homolog 1 (Akt1) [9].
The crystal structure of human SIRT1 (a homolog of yeast Sir2)
reveals a large groove intersected by a pocket lined with hydro-
phobic residues, conserved with class-specific protein-binding
sites of each Sir2 class [10]. Activity of most of the sirtuins is
controlled by posttranslational modifications, as well as the
availability of NADþ . It has been shown that they are phosphory-
lated at N- and C-terminals, which play a role in substrate binding
[11]. Moreover, in addition to phosphorylation, it appears that S-
nitrosylation of SIRT1 impairs the catalytic activity of enzymes via
a nitrosylated glyceraldehyde-3-phosphate dehydrogenase-
mediated process [12]. Additionally, thioredoxin (Trx) regulates
cellular redox balance through reversible oxidization of its redox-
active cysteine residues (-Cys-Gly-Pro-Cys-), which can mediate
protein S-denitrosylation [13–15] and hence the activity of
sirtuins. The deacetylase domain of sirtuins consists of approxi-
mately 250 amino acids, differentiated by divergent N- and C-
terminal extensions [16]. In the budding yeast Saccharomyces
cerevisiae, the Sir proteins are involved in a wide array of cellular
processes, including the nonhomologous end-joining repair of
DNA [17], the stabilization of the replication forks in the riboso-
mal (r) DNA to prevent DNA breaks, recombination, and the
generation of extrachromosomal rDNA circles [18], which leads
to aging of this organism [19].
One of the first studies that linked sirtuins to aging was
based on the observation that proteins encoded by SIR genes
are responsible for silencing the rDNA of S. cerevisiae [20]. The
same group of investigators also demonstrated that Sir2 is
redox sensitive because of its NADþ dependence. Moreover,
they showed that sirtuins have deacetylase activity from
eubacteria to humans [21]. Guarente and his group then
demonstrated that redistribution of the Sir2 complex from a
telomere to the nucleolus is associated with aging in yeast
[19,22], and overexpression of this gene extends their life span
[23]. Sinclair and co-workers showed that life extension in
yeast could be done via the salvage pathway of NADþ [24],
and life-span extension during caloric restriction (CR) is
associated with activation of Sir2 genes in yeast and the
mammalian homolog SIRT1 of human cells [25,26]. Now,
mounting data suggest an active role for sirtuins in aging
and age-associated diseases. However, as with most phenom-
ena in science, the convincing effects of sirtuins in mammalian
aging are not without debate [27].
This paper reviews the redox sensitivity of sirtuins and the
role of these lysine deacetylases, especially SIRT1, in the aging
process. The authors also crucially review the data of knockout
and overexpression models, as well as the effects of CR
and physical exercise. The effects of resveratrol, which is a
potent stimulator of SIRT1, have been reviewed elsewhere
[28–31].
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Fig. 1. The suggested mechanisms between the availability of NAD and the activities of sirtuins and PARP is shown. Metabolic challenges modulate NAD levels, NAD:NADH
ratio, and cell fate by shifting to either pro- or antiapoptotic pathways.
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Role of sirtuins in cellular redox balance
Redox balance and sirtuins: up- and downstream regulators
The activity of sirtuins can be readily modified by the availability
of NADþ , expressed as a function of NAD:NADH ratio, which is a
marker of cellular redox balance. Metabolic challenges, such as
hypoxemia–ischemia and reoxygenation, result in deceased NAD
and nicotinamide phosphoribosyltransferase (NAMPT) levels and
decreased activity of sirtuins [32–35]. It was recently shown that
treatment with glycated low-density lipoprotein resulted in increased
ROS production in vascular endothelial cells and in lowered mito-
chondrial membrane potential, the NAD:NADH ratio [36]. It has been
shown that glutamate-induced excitotoxicity in neurons and ische-
mia in mouse brains result in marked decreases in NADþ levels,
which is a precausative step before cell death [32]. ROS can readily
induce DNA damage, and in response to DNA strand breaks poly
(ADP-ribose) polymerase 1 (PARP1) consumes significant amounts of
NADþ to produce poly(ADP-ribose) polymers on target proteins in a
process called poly-ADP-ribosylation [37]. Significant DNA damage-
associated PARP activation can lead to NADþ depletion resulting in
energy crisis [38].
Hence, administration of nicotinamide, which is a NADþ
precursor and a noncompetitive inhibitor of SIRT1, has rescued
cells from apoptosis and necrosis [32]. On the other hand
resveratrol supplementation did not increase cell survival.
In contrast, in ischemic–reperfused cardiomyocytes resveratrol
supplementation mediated cell survival via mitogen-activated
protein kinase pathways [39].
The concentration of NADþ seems to be crucial, because when
PARP1 was knocked out the phenotype of mice resembled the
SIRT1 of overexpressed phenotypes, and similar phenomena have
occurred when PARP1 was inhibited by pharmacological agents
[40]. These data strongly point to a competition between PARP1
and SIRT1 for the common cofactor NADþ (Fig. 1). On the other
hand, when the NADþ level was depleted first by oxidants, such
as hydrogen peroxide or cigarette smoke, then the PARP1 inhibi-
tion was not effective in gaining back SIRT1 activity. Nonetheless,
the NADþ content was restored [35]. One of the causative factors
could be that oxidants resulted in carbonylation of amino acid
residues of SIRT1, which, in turn, could curb the activity of the
enzyme [35,41]. This could happen with aging also. Koltai and
colleagues [42] observed that with aging there is an increase
in the level of SIRT1, which is associated with decreased activity
of the enzyme and appears to be due to increased carbonylation.
In this study, carbonylation of SIRT1 was not studied specifically;
however, the overall carbonylation of the cytosolic proteins has
been found to significantly increase in older animals. In a recent
study in which pelvic human skin samples were used, DNA
damage was positively correlated with aging and negatively
correlated with NADþ levels [43]. Therefore, it seems that
oxidants could affect sirtuins via depletion of NADþ and oxida-
tive modification of amino acid residues, leading to decreased
activity or level of the enzyme [40,44]. On the other hand, it has
also been shown that the overexpression of SIRT1 has beneficial
effects in resistance to oxidative stress [39,44,45].
The effects of sirtuin-regulated transcription factors on redox balance
Sirtuin-mediated deacetylation of key transcription factors results
in altered gene expression of key antioxidant enzymes or those
producing ROS. Here we focus on redox regulation by sirtuins via
p53, FOXOs, nuclear factor kB (NF-kB), and peroxisome proliferator-
activated receptor g coactivator 1a (PGC-1a) as examples.
SIRT1 is involved in stress responses, cellular metabolism, and
aging through deacetylation of a variety of substrates including
p53. p53 is acetylated by CBP/p300 acetyltransferases at lysine
residues, including Lys 370, 372, 382, and 386 at the carboxy-
terminal region [46,47]. Activated p53 then enhance ROS produc-
tion through mitochondrial dysfunction and/or increased expres-
sion of genes that are involved in redox modulation, such as the
p53-upregulated modulator of apoptosis (PUMA), NADPH activa-
tor A (NOXA), and p53-induced gene 3 (PIG3) [48,49]. In addition,
it seems that NADPH oxidase 1-generated ROS inhibit the acet-
ylation of p53 at Lys 382 via SIRT1. Deacetylation at Lys 382 is
important in the control of gene expression from PUMA, NOXA,
and PIG3, i.e., the proapoptotic function of p53 [50]. Interestingly,
p53 via p21 indirectly activates nuclear factor (erythroid-derived
2)-like 2 (Nrf2), a central transcription factor in the antioxidant
response. Nrf2 binds to the antioxidant-response element 2, a cis-
acting enhancer found in promoters, and, via increased antiox-
idant gene expression, counteracts oxidative challenge [51].
In mammals there are four FOXO transcription factors, and,
among them, FOXO1, FOXO3a, and FOXO4 are involved in redox
regulation [52,53]. FOXOs are negatively regulated by the phos-
phatidylinositol 3-kinase–Akt signaling pathway. When cells
were treated with hydrogen peroxide, the FOXO3 acetylation
was increased by CBP/p300 and, as a result, the resistance against
oxidative stress was enhanced [54]. Moreover, oxidants caused
translocation of FOXO3 into the nucleus, where it can be deace-
tylated by SIRT1, which would enhance the activation of GADD45.
This is important for stress resistance by the induction of DNA
repair, because GADD45 is required for efficient DNA base exci-
sion repair (BER) and nucleotide excision repair (NER) [54,55].
In addition, FOXO3 directly activates the transcription of Mn-
superoxide dismutase (SOD) and catalase [56] to attenuate the
toxicity of mitochondrial-derived superoxide anion and hydrogen
peroxide, thereby preventing damage to genomic and mitochon-
drial (mt) DNA, lipids, and proteins. In addition to FOXO3, FOXO1
can also alter redox states. For instance, Akt-mediated phosphor-
ylation of PGC-1a at serine 570 results in inactivation, and this
conformational change leads to reversible disruption of the
FOXO1 response element of the catalase promoter, therefore
curbing the expression of catalase [57]. In addition, it appears
that FOXO4 inhibits NF-kB and thereby the proinflammatory
chemokine/cytokine expression and ROS production associated
with the activation of inflammatory cells [58].
NF-kB-dependent signaling plays a role in the aging process,
with a wide range of effects in addition to inflammation [59]. NF-
kB is a family of inducible transcription factors that plays a
central role in controlling expression of networks responsible for
proinflammatory gene expression, cell proliferation, differentia-
tion, or apoptosis [60]. NF-kB release from cytoplasmic inhibition
is necessary, but not sufficient, for target gene induction, e.g., that
induced by ROS RelA/p65 phosphorylated at serine 276, which is
coincident with its release from IkBa in the canonical pathway.
Upon phosphorylation, RelA/p65 translocates into the nucleus
and mediates the promoter-specific recruitment of p300/CBP,
which acetylates it at lysine 510 to enhance transcription. It has
also been shown that SIRT1 deacetylates the RelA/p65 on lysine
310 and thus blocks the transcriptional activity of NF-kB [61],
resulting in active silencing of the chromatin (Fig. 2). SIRT1
has been shown to be capable of decreasing NF-kB-induced
inflammation by deacetylation and prevents the tumor necrosis
factor a (TNF-a)-mediated activation of matrix metalloproteinase
9, interleukin 1b (IL-1b), IL-6, and inducible nitric oxide synthase
[62].In addition, it has been suggested that SIRT1 binds to the
promoter regions of IL-1b and TNF-a in a cell model of sepsis and
plays a role in epigenetic regulation during endotoxin tolerance [63].
However, it is clear that suppression of NF-kB activity by SIRT1
modulates redox signaling, not just by regulating inflammation but
also through the expression of Mn-SOD [64,65].
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PGC-1-related proteins are expressed ubiquitously, but PGC-1a
and -1b are enriched in mitochondria-rich tissues such as cardiac
and skeletal muscles. PGC-1a is a master transcriptional coactiva-
tor that modulates the gene expression involved in energy meta-
bolism and energy expenditure. PGC-1a is a direct link between
external physiological stimuli and the regulation of mitochondrial
biogenesis. PGC-1a regulates the activity of a large number of
transcription factors, including peroxisome proliferator-activated
receptors c and a, estrogen receptor-related a, FOXO1, hepatocyte
nuclear factor 4a, and nuclear respiratory factor 1. Moreover, PGC-
1a also regulates gene transcription encoding mitochondrial elec-
tron transport chain proteins, uncoupling protein 2 (UCP2) and
UCP3, and key antioxidant enzymes, such as Cu,Zn-SOD, glu-
tathione peroxidase,Q2 and catalase [66,67]. Its transcriptional coac-
tivator function is primarily regulated by acetylation via p300/CBP
and deacetylation by SIRT1 [68]. Mitochondrial biogenesis itself
can be an important cog in redox homeostasis, because for the
same ATP production more mitochondria can work at a lower
respiratory capacity, and then fewer ROS are produced. Contrarily,
decreased mitochondrial capacity at metabolic stress, such as
exercise or ischemia, would result in enhanced ROS production.
These observations support PGC-1a’s active involvement in anti-
oxidant defense [69]. Inflammation is associated with increased
ROS production and oxidative damage, and the antioxidant role of
PGC-1a is further supported by the anti-inflammatory effects of
this coactivator [70].
Sirtuins in regulation of genome integrity
One of the first studies on sirtuins and DNA repair as well as
telomere silencing was done in yeast cells (S. cerevisiae). These
studies revealed that Ku protein interacts with sirtuins during
DNA double-strand break (DSB) repair of telomere regions
[71,72]. Studies have also shown that SIRT1 deacetylates Ku70
in mammalian cells, revealing antiapoptotic effects [26,73].
Another sirtuin family member, SIRT6, interacts with PARP1 to
enhance the efficiency of repair of DSBs [74]. SIRT6 is also
important for other DNA repair pathways, because in SIRT6-
ablated cells, overexpression of a single-strand break gap-filling
protein, DNA polymerase b, rescued cells, implying that SIRT6-
mediated deacetylation has a crucial role in BER processes [75].
Consequently, a lack of SIRT6 in knockout mice decreased the life
span [76]. Moreover, many human cancers show decreased levels
of SIRT1, and SIRT1 mutant mice exhibit an increased incidence of
cancer [77].
The apurinic/apyrimidinic endonuclease 1 (APE1) plays a
central role in the repair of oxidized and alkylated bases in
mammalian genomes via the BER pathway. APE1 also functions
as redox effector factor 1 for several transcription factors, includ-
ing activator protein-1 (AP-1), HIF1a, and p53 [78]. Importantly,
both repair and transcriptional function (coactivator and core-
pressor) of APE1 are modulated by acetylation in redox-
dependent and redox-independent mechanisms [79]. It has also
been shown that APE1 is a target of SIRT1-mediated deacetyla-
tion, and the administration of resveratrol increases the activity of
this important BER enzyme [80]. Along with APE1, human 8-
oxoguanine-DNA glycosylase 1 (OGG1) is the major DNA glyco-
sylase for excision of 7,8-dihydro-8-oxoguanine (8-oxoG) and
ring-opened fapyguanine. OGG1 has been shown to be acetylated
by p300/CBP at lysines 338 and 341, which results in a significant
increase in its activity [81]. We have recently demonstrated that
Ac-OGG1 is present in human skeletal muscle and rat tissues, and
the level of acetylation decreases with aging, whereas a parallel
pattern was found for SIRT1 activity [82,83]. Moreover, we have
shown that resveratrol administration decreases the acetylation
level of OGG1 and ablation of SIRT1 by siRNA-increased levels of
Ac-OGG1. This finding suggests that SIRT1 is counteracted by
OGG1 (Sarga, Q3Z. Radak, and I. Boldogh, unpublished observation).
It has been recently shown that the OGG1–8-oxoG complex
interacts with and catalyzes GDP–GTP exchange in the canonical
Ras family GTPases H-, K-, and N-Ras. These data imply that in the
presence of 8-oxoG base, OGG1 acts as a guanine nucleotide
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Fig. 2. Sirtuins are involved in a complex way in redox regulation. By the deacetylation of transcription factors, such as p53, FOXOs, NF-kB, and PGC-1a, they modulate the
transcription of pro- and antioxidant genes, mitochondrial biogenesis, activity of oxidative damage-repairing enzymes, and chromatin structure.
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exchange factor [84]. In turn, Ras–GTP via Raf1 (v-raf-1 murine
leukemia viral oncogene homolog 1) phosphorylates the mitogen-
activated kinases MEK1,2/ERK1, which may lead to ROS produc-
tion. In addition to BER, NER is also modulated by sirtuins,
because the xeroderma pigmentosum group A is deacetylated
and suppressed by SIRT1 [85,86]. Moreover, it was also shown
that human cancers have decreased levels of SIRT1, and SIRT1
mutant mice exhibited an increased incidence of cancer [77].
Sirtuins in protein stability and cellular stress response
Housekeeping of oxidative stress and damage is crucial in
redox balance as it affects the fate of the cells. A group of genes
involved in preserving cellular homeostasis during stress condi-
tions, called vitagenes, and sirtuins, among others, are involved in
a wide spectrum of cellular defense [14,87,88]. Indeed, one of the
ways by which sirtuins regulate the stress response is through
protein stability, which can readily affect the levels of oxidatively
modified/damaged proteins [89]. One of the ways by which SIRT1
protects cells from oxidative stress is its involvement in the
integrated stress response pathway via eukaryotic initiation
factor 2a (eIF2a). During stress, cells suppress the levels of
protein synthesis and mobilize most of the available sources to
cope with stress [90], and the reduction in eIF2–GTP levels leads
to a general reduction in global protein synthesis. It turns out that
SIRT1 interacts with mediators of eIF2a dephosphorylation,
suggesting a role for SIRT1 in the eIF2a-related early stress
response [90], which partly depends on the NAD:NADH ratio.
Cellular stress response is also mediated by heat shock
transcription factor 1 (HSF1), which when acetylated negatively
regulates DNA binding. On the other hand, SIRT1-mediated
deacetylation of HSF1 enhances its binding to the heat shock
protein 70 promoter by maintaining HSF1 in a deacetylated, DNA-
binding-competent state [91]. This finding established the role of
SIRT1 in the heat shock response and longevity, because HSF1 has
been linked to longer life spans [92], as well as in protein stability,
because heat shock proteins are important modulators of protein
degradation. Indeed, the effect of acetylation on protein stability
is another acting point in the cellular stress response by which
redox balance is supervised by sirtuins [82,93–96].
The role of acetylation and deacetylation of protein stability has
been reviewed by others [97,98]. One of the first proteins for which
acetylation was linked to stability was p53 [47,99]. Acetylation of
lysine residues prevents ubiquitination of the given residues, thus
hampering signaling for proteolytic degradation [98]. Indeed,
inhibition of SIRT1 by nicotinamide decreased the polyubiquitina-
tion of FOXO3 and hence the protein levels of this transcription
factor [96]. The activation of SIRT1 resulted in enhanced degrada-
tion of FOXO3 by the proteasome system. Aging results in a loss of
the activity of SIRT1, which is associated with increased levels of
lysine acetylation in rat brain and skeletal muscle [42,82,100]. The
level of acetylated lysine residues correlated well with that of
carbonylation, which may mean that acetylated lysine could not
have been ubiquitinated and degraded by proteasomes. If this
happens, the half-life of proteins increases, which is believed to
take place with aging, resulting in the enhanced accumulation of
damaged proteins and consequently decreased physiological func-
tion [101]. However, acetylation of nonhistone proteins also takes
place in a very selective manner [102].
Acetylation of histone residues by sirtuins alters the transcrip-
tion from genes that are involved in redox homeostasis (Fig. 3).
For instance, SIRTs 1–3 and 6 are involved in shaping chromatin
structure, and the well-known target of SIRT1 deacetylation is the
acetylated histone H3 lysine 9, which is a precausative step
toward the methylation of the same lysine residue by the histone
methyltransferase suppressor of variegation (Suv) 39h1 [103].
SIRT1 preserves pericentromeric heterochromatin via stabiliza-
tion of Suv39h1 by preventing the polyubiquitination of lysine 87
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Fig. 3. Sirtuins regulate the stability of proteins, which in turn would affect cell and organ function. Modulation of DNA repair could be associated with longevity,
metabolic abnormalities, cancer, and aging.
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of this methyltransferase by E3-ubiquitin ligase [104]. The stabi-
lization of Suv39h1 under stress conditions, such as oxidative
stress, results in enhanced protection of chromatin structure.
Sirtuins and mammalian aging
The involvement of sirtuins in the aging of yeast, such as the
silencing of rDNA, is quite different and less complex than that
occurring in mammalian systems. However, even in yeast, the life
extension effects of overexpression of Sir2 have been questioned
recently [27]. It appears that SIRT1 regulates mammalian FOXOs
more than does the bacterial homolog Sir2, and the inhibition of
FOXOs and p53 results in an antiapoptotic process, which is
closely related to the resistance to oxidative stress. Deacetylation
of p53 by SIRT1 attenuates the DNA-binding and transcriptional
activity, whereas deacetylation of FOXOs can result in suppres-
sion of transcription from proapoptotic genes and enhance
activity of those that are involved in oxidative stress resistance
[54]. Therefore, the effects of SIRT1 on these transcription factors
are to promote cell survival in mammals. Recently, it was
reported that mammalian sterile 20-like kinase (MST1) can
inhibit SIRT1 by phosphorylation in response to DNA damage,
which consequently leads to apoptosis through the acetylation of
p53. This observation further supports the key role of SIRT1 in
cellular resistance during oxidative stress [105]. The controlling
role of SIRT1 on p53 can alter redox balance, because the
proapoptotic role of p53 can induce genes involved in ROS
production, and this transcription factor can activate enzymes
in the antioxidant system [106,107]. It is suggested that low
levels of deacetylated p53 suppress cellular levels of ROS, whereas
high levels of acetylated p53 induce ROS production-related
genes (see review in [108]).
In terms of aging, it has been shown that overexpression of
SIRT1 in primary fibroblasts decreased acetylation of p53 and
antagonized PML/p53-induced premature aging of cells in culture
[109]. The question is whether this activity occurs at the level of
the organism in vivo as well. The finding that there is an increase
in the levels of p53, FOXO1, and SIRT1 in the nuclei of cells of old
animals [110] may be indicative of a complex setting in mam-
mals. In sporadic inclusion-body myositis, which is an aging-
associated muscle disease, it was found that deacetylation of p53
was decreased [111]. Aging results in decreased intracellular
levels of NADþ and NAD:NADH ratio in various organs of old
rats, and this finding was associated with decreased activity of
SIRT1 and increased acetylation of p53 [33]. Moreover, aging
processes resulted in a lower activity of complexes I–IV in the
mitochondria and enhanced oxidative DNA damage [33]. In
support, an increase in SIRT1 levels has been shown in skeletal
muscle of aged animals, and this was associated with decreased
activity of the enzyme along with lower levels of NAMPT and
increased levels of oxidative damage [42]. During the aging
process, the level of noncoding microRNA R-34a and microRNA
R-93 is increased in rat liver, and these microRNAs suppress the
activity of specificity protein 1 and Nrf2 transcription factors,
resulting in decreased SIRT1 and microsomal glutathione S-
transferase 1 expression [112]. This posttranslational repression
of SIRT1 and microsomal glutathione S-transferase 1 naturally
results in decreased oxidative defense during aging in the
rat liver.
There is a paucity of these studies on human healthy aging and
sirtuins. SIRT1 plays a role in telomere length, which is used as a
marker to appraise the aging process [113,114]. A single-
nucleotide polymorphism in the SIRT1 gene and another in the
30 flanking region of XRCC6 interfered with the length of the
telomere in human leukocytes and aging [115]. Moreover, it was
also reported that the frequency of the minor allele of SIRT1 was
enhanced in older subjects. Data from human and animal studies
revealed that SIRT1 could modulate and deacetylate endothelial
nitric oxide synthase (eNOS), which in turn resulted in altered NO
production. The acetylation level of aortic eNOS of 30-month-old
rats was many times higher than that of young rats [116]. Sirtinol
was used to inhibit SIRT1 in this study, and it abolished the age-
associated difference in endothelium-dependent dilatation, and
the results gained from the samples of endothelial cells, obtained
from the brachial artery of young and old subjects, confirmed that
in healthy aging SIRT1 could play a role in endothelial dysfunction
[116].
mRNA analysis revealed no age-associated changes in SIRT1
and SIRT3 expression in skeletal muscle in young vs old subjects
[117]. Similar results were obtained in the rat myocardium of
young and old rats [118]. It seems that, as a result of aging, SIRT1
and SIRT6 levels increase in rat skeletal muscle, whereas the
activity of OGG1 is decreased [42]. Interestingly, the SIRT1 levels
in the hippocampus of the same animals decreased as a result of
aging, whereas we found elevated levels of SIRT3 [82]. An
increased level of 8-oxoG in the hippocampus with elevated
levels of OGG1 was observed in aged subjects. However, when
we checked the acetylation level of OGG1, it was found that aging
significantly decreased the Ac-OGG1 content. Therefore, it was
suggested that the drop in OGG1 acetylation could account for the
increased 8-oxoG levels in cellular DNA of hippocampus [82].
We further studied the acetylation pattern of OGG1, and our
unpublished data suggested that SIRT1 interacts with and deace-
tylates OGG1 as in case of APE1.
Analysis of specimens from human brain regions of healthy
and Alzheimer disease (AD) subjects showed that SIRT1 expres-
sion at both the RNA and the protein level is significantly
decreased in the parietal cortex of AD patients, whereas cortical
expression was not affected [119]. Global cognition scores
obtained before death would suggest that the decrease in SIRT1
levels is related to the accumulation of amyloid-b and t in the
cerebral cortex of persons with AD [119]. On the other hand, it
was also reported that in age-related cataracts in healthy older
humans there was a lower level of SIRT1 expression, and the
levels of SIRT1, p53, FOXO3, and FOXO4 were comparable to data
from young subjects [120]. It is also clear that the antiapoptotic
role of SIRT1 can contribute to increased tumor growth [121],
which can be attenuated by SIRT1 inhibitors. The complexity of
SIRT1 in senescence involves stem cell differentiation, which
emphasizes the role of SIRT1 in controversial processes during
aging [122].
Sirtuin knockout and transgenic animal models
Despite drawbacks, knockout animal models offer one of the
most powerful means for studying gene function. There are power-
ful data showing that knockdown or overexpression of sirtuins
results in shorter or longer life spans, respectively, in model
organisms from yeast to mice [4,76], although the information in
the literature is not unequivocal.
It has been reported that in SIRT1 knockout mice, although the
oxidative damage was decreased in the brain, the life span was
shorter, and CR was not effective [123]. In addition, inhibition of
SIRT1 decreased insulin-like growth factor 1 (IGF-1) signaling and
increased resistance against oxidative challenge. According to
that report, SIRT1, under certain physiological conditions,
enhances IGF-1 signaling by deacetylating insulin receptor sub-
strate 2 (IRS2), resulting in Ras/ERK activation, increasing ROS
production and altering redox signaling [123]. Knocking out SIRT1
in mice with A53T a-synuclein mutation decreased, while over-
expression increased, the life span of transgenic mice [124].
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Moreover, in another disease model, which was developed to
mimic Huntington disease, it was found that ablation of SIRT1
caused exacerbation of brain pathology, whereas brain-specific
overexpression of SIRT1 attenuated the consequences of Hunting-
ton disease, partly by the upregulation of brain-derived neuro-
trophic factors leading to enhanced survival [125].
On the other hand, data from another research group indicated
that ablation of SIRT1 resulted in impaired memory, cognitive
function, and spatial learning, and the expression of genes impor-
tant for synaptic plasticity and metabolism was decreased [126]. In
contrast, SIRT1-overexpressing mice showed normal cognitive
functions and learning. It should be pointed out that overexpres-
sion of SIRT1 in striatum and hippocampus, under the control of
the a subunit of Ca2þ–calmodulin-dependent protein kinase II
promoter, decreased glucose transporter type 4 level in skeletal
muscle and increased body fat. This genetic manipulation altered
the performance in an open-field test, through the deacetylation of
IRS2, which induced phosphorylation of IRS2 and ERK1/2 in the
striatum of these mice [127]. SIRT1 knockout mice revealed that
SIRT1 is important to development, and the hyperacetylation of
p53 was observed in SIRT1-ablated models, which may indicate
that SIRT1 is crucial for p53-mediated apoptosis [128]. Indeed, it
has been shown that SIRT1 mutant and p53 mutant mice develop
tumors in multiple tissues, which also emphasizes the possible role
of SIRT1 in the regulation of p53 [77].
It has been reported that SIRT1 knockout mice have greater
mobility; when they were exposed to treadmill running and the
rotarod test, their performance was better than that of wild-type
mice [129]. It would be important to understand how the ablation
of SIRT1 in this model could result in better physical performance.
On the other hand, overexpression of SIRT1 in mice also resulted
in better performance on the rotarod test, and their phenotype
resembled those of mice that are exposed to CR [130]. Therefore,
overall, data from knockout models clearly showed how complex
the role of SIRT1 is in mammalian physiology and how carefully
the knockout data need to be evaluated in terms of SIRT1’s
function. A major problem of these studies is that the proteins
that are targets of SIRT1 are not apparent, in most cases, nor is
how deacetylation of those proteins is mechanistically related to
the outcomes observed.
Regulation of sirtuins by CR and exercise
CR is known to increase mean and maximum life spans, and
regular physical exercise can also enhance mean life span; more-
over, sirtuins are indicated as being involved in both cases.
For example, a number of studies have shown that sirtuins,
especially SIRT1, mediate CR-induced longevity. However, the role
of Sir2 in CR was questioned by Kaeberlein and co-workers
[131,132], but their model used yeast, which differs from mamma-
lian models. When 12-month-old rats were subjected to CR, as 60%
of the daily food allotment, the result was a downregulation of the
IGF-1 pathway and SIRT1-mediated regulation of p53, Ku70, and
FOXO3 [26]. This was one of the first demonstrations of the power-
ful effect of CR on SIRT1-associated signaling. In another rat study, in
which the dietary amino acids, except methionine, were restricted
to 40%, increased SIRT1 levels were found along with unchanged
levels of PGC-1a and of mtDNA damage, but with decreased levels
of mitochondrial protein oxidation [133].
Thioredoxin-interacting protein (TXNIP) has been suggested to
elevate sensitivity to oxidative stress through inhibition of Trx
[134], having an effect opposite to that of sirtuins on life span
[135,136]. Consistently, it has been shown that limited calorie
availability inhibited TXNIP and slightly induced SIRT1, whereas
resveratrol had biphasic effects [137], and its inhibitory role on
TXNIP was mediated through AMPK pathways.
Csiszar and co-workers [138] demonstrated that life-long CR
significantly decreased age-associated vascular dysfunction, oxi-
dative stress, and NF-kB activity. They also showed from a
relating cell culture that inhibition of SIRT1 by silencing RNA
eliminated the beneficial effects of CR on inflammation and
antioxidants, possibly indicating that SIRT1 is actively involved
in the CR-mediated signaling process. Aging results in decreased
protein levels of SIRT1 in the hippocampus [82], and this decrease
can be attenuated by CR [139], which may mean that CR could act
via SIRT1. Studies on cAMP responsive-element binding 1 (CREB1)
knockout mice revealed that CR (given as 60% of the ad libitum
normal diet) decreased SIRT1 levels in the hippocampus and
cortex, whereas in wild-type animals the SIRT1 was upregulated
by CR [140]. That report presented evidence that CR in the brain
was mediated by CREB1, which in turn induced SIRT1 expression,
and suggested that SIRT1-associated metabolic processes played a
role in neuronal plasticity. In addition, SIRT1 is also involved in
the effects of CR in skeletal muscle, because it has been shown
that the transcription factor signal transducer and activator of
transcription 3 is deacetylated and therefore inactivated by SIRT1
during CR, leading to a downregulation of insulin-stimulated
phosphoinositide 3-kinase, resulting in enhanced insulin sensi-
tivity [141]. Moreover, another study reported that SIRT1, via its
interaction with AP-1, promotes macrophage function during CR
[142]. Studies on CR have resulted in some controversial issues on
mitochondrial biogenesis, at least those using experimental
rodents [143,144]. Data from human skeletal muscle provide
evidence that CR can result in enhanced mitochondrial mass
and increased SIRT1 levels [145]. Therefore, it seems to be
supported by a number of papers that CR indeed acts through
SIRT1-controlled molecular processes in mammalian systems.
The effects of exercise, similar to those of CR, appear to be
systemic and complex [146], as it has been shown that both a
single bout of exercise and endurance training result in elevated
levels of SIRT1 protein in the skeletal muscle of rats [147].
Prolonged moderate exercise training resulted in increased SIRT1
levels in rat hearts. Moreover, the results demonstrated an
enhanced content and expression of FOXO3, along with elevated
expression of GADD45 [148]. In addition, this study concluded
that exercise normalizes the aging-associated alteration in heart
and adipose tissue. Similar conclusions were drawn with skeletal
muscle, whereby exercise counterbalanced the age-associated
decline in NAMPT content and decrease in SIRT1 activity [42].
Data indicate that exercise can attenuate the age-associated
decrease in mitochondrial protein synthesis in skeletal muscle
of rats, which included the loss of SIRT1 and PGC-1a levels as well
[149]. Similar data have been reported for mouse liver [150].
Studies using human skeletal muscle have also shown
exercise-related upregulation of NAMPT content [151], an impor-
tant adaptive response to exercise-induced metabolic challenge,
which can help to regulate redox balance through the NAD:NADH
ratio, thus modulating the activities of sirtuins, PARP, and lactate
dehydrogenase. Two weeks of high-intensity interval training in
humans resulted in significant increases in mitochondrial biogen-
esis, increased nuclear PGC-1a content, and increased GLUT4
content, all of which appear indicative of improved insulin
sensitivity of these subjects [152]. A single bout of exercise
increased the SIRT1 expression in young individuals, whereas it
failed to have similar effects on the aged, and, in general, young
subjects responded with greater levels of mRNA expression of
mitochondrial biogenesis-related genes [117].
Exercise appears to increase SIRT1 levels in the hippocampus
[153], but not in the cerebellum [100]. However, data from other
studies have shown that age-associated decreases in brain
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function can be alleviated by regular exercise [82,154]. Moreover,
recent data indicate that the age-induced increases in Ku70 levels
can be attenuated by the combined effects of IGF-1 and exercise
[155]. The protein content of SIRT1 decreased, whereas SIRT3
increased, with aging. Exercise-induced redox and metabolic
challenges and adaptive responses to regular activity lead us to
suggest that sirtuin-mediated metabolic pathways could be
important to mitochondrial biogenesis, fuel availability, antiox-
idant response, and DNA repair.
Conclusion
Sirtuins are master regulators of a wide range of metabolic
processes in mammalian cells, and aging affects sirtuin-associated
molecular pathways. Sirtuins could be on both sides of redox
regulation, because the oxidative stress-related loss of NAD
content would affect their activity. However, by their interactions
with a number of transcription factors that target pro-oxidant and
antioxidant genes, such as p53, NF-kB, PGC-1a, and FOXOs,
sirtuins are not just dependent but also regulatory factors of the
redox state. In addition, the role of sirtuins in oxidative damage
repair is another pathway that could significantly alter the redox
state. Accumulating data suggest that sirtuins, especially SIRT1,
are potential targets for natural and pharmaceutical interventions
into aging processes. Among natural interventions, it seems that
CR and regular physical exercise act through sirtuin-associated
processes, which has promise to improve health.
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